-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Recently, Sihuan Pharmaceutical issued an announcement stating that Foshan Derek Pharmaceutical (a subsidiary of Pharmadax Inc.
Data show that Metoprolol is the world's first selective β1 receptor blocker, which can reduce the risk of bronchoconstriction, so it has become a commonly used drug for chronic heart failure
Sales of terminal metoprolol tablets in public medical institutions in China in recent years (unit: 100 million yuan)
Source: Mi Nei.
According to data from Meinenet, the sales growth rate of terminal metoprolol tablets in China's urban public hospitals, county-level public hospitals, urban community centers, and township health centers (Chinese public medical institutions) has maintained above 10% in the past two years.
Source: One piece retrieval from Mi Nei.
The main products of Metoprolol Tablets include Metoprolol Succinate Sustained Release Tablets, Metoprolol Tartrate Tablets, Metoprolol Tartrate Sustained Release Tablets (Ⅱ), etc.
At present, five companies including Yichang Renfu Pharmaceutical, Zhejiang Prokangyu Pharmaceutical, Guangdong Dongyang Sunshine Pharmaceutical and other metoprolol succinate sustained-release tablets are under review and approval for generic 4 types of production
Source: Listed company announcements, Mi Nei.